Loading company…
R3 Vascular develops bioresorbable vascular scaffolds for peripheral arterial disease.
Founded in 2019 and based in Mountain View, US, R3 Vascular develops medical devices, including bioresorbable vascular scaffolds for peripheral arterial disease. In May 2024, it raised USD 87 million in Series B funding led by Deerfield Management and 415 CAPITAL, valuing the company at USD 126.09 million post-money. The company plans to use the funding for research and development and to expand its market presence.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in